🔬 Inflammation Markers and Liver Cancer: What Albumin Tells Us About Tumor Aggressiveness
Hepatocellular carcinoma (HCC) is the most common form of liver cancer, often arising in the context of chronic liver inflammation. But can the level of inflammation in the body predict how aggressive a liver tumor will be — or even how long a patient will live? A newly published study in the Journal of Biomedical Research & Environmental Sciences offers a deep dive into this question. Researchers Brian Irving Carra and Rossella Donghiab analyzed data from over 6,700 HCC patients to assess which blood-based inflammation markers best correlate with tumor severity and patient survival. 📊 Key Markers Investigated: Albumin : A protein made by the liver, reflecting both liver function and systemic inflammation. CRP (C-reactive protein) : A marker of systemic inflammation. PLR (Platelet-to-Lymphocyte Ratio) : A ratio thought to reflect immune response and inflammation. HALP (Hemoglobin, Albumin, Lymphocyte, Platelet Score) : A combined mar...